Duane Nash's Net Worth
-$318 Thousand
Who is Duane Nash?
Duane Nash does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IMMUNIC, INC., and Akebia Therapeutics, Inc..
SEC CIK
Duane Nash's CIK is 0001591098
Past Insider Trading and Trends
2015 was Duane Nash's most active year for acquiring shares with 5 total transactions. Duane Nash's most active month to acquire stocks was the month of May. 2019 was Duane Nash's most active year for disposing of shares, totalling 9 transactions. Duane Nash's most active month to dispose stocks was the month of December. 2014 saw Duane Nash paying a total of $824,390.44 for 71,386 shares, this is the most they've acquired in one year. In 2014 Duane Nash cashed out on 35,799 shares for a total of $402,104.34, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNIC, INC. (IMUX) Snapshot price: $1.34
Executive ChairmanDuane Nash owns 16,032 units of Common Stock which is worth $21,482.88. From 2014 to 2024 Duane Nash acquired a total of 41,157 shares in IMMUNIC, INC. at a cost of $125,032.04, Duane also disposed a total of 18,330 shares of IMMUNIC, INC. equalling to $87,356.01.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +33.24% | 4K |
$5.03 | $50,300.00 | 16.03K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +7.13% | 1K |
$9.80 | $9,800.00 | 15.03K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +39.87% | 4K |
$12.75 | $51,000.00 | 14.03K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
| +4,793.66% | 9.83K |
$7.08 | -$87,356.01 | 10.03K |
Scheduled
|
Dec 2 - Dec 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +90.19% | 3.9K |
$3.12 | $12,182.04 | 8.22K |
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
| +1.08% | 100 |
$17.50 | $1,750.00 | 9.32K |
Oct 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akebia Therapeutics, Inc. (AKBA) Snapshot price: $1.36
InvestorDuane Nash owns 21,499 units of Common Stock which is worth $29,238.64. In the year 2014 Duane Nash filed a total of 21 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| -4.44% | -1.00K |
$14.62 | -$14,620.00 | 21.5K |
Scheduled
|
Feb 15
| ||
Form 4
| -5.02% | -1.19K |
$19.64 | -$23,332.32 | 22.5K |
Scheduled
|
Oct 2
| ||
Form 4
| -4.01% | -990.00 |
$14.27 | -$14,127.30 | 23.69K |
Scheduled
|
Jul 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| -3.86% | -991.00 |
$9.20 | -$9,119.28 | 24.68K |
Scheduled
|
Apr 3
| ||
Form 4
| -7.16% | -1.98K |
$10.46 | -$20,711.00 | 25.67K |
Scheduled
|
Jan 3
| ||
Form 4
| -6.69% | -1.98K |
$8.96 | -$17,746.00 | 27.65K |
Scheduled
|
Oct 3
| ||
Form 4
| -6.26% | -1.98K |
$7.48 | -$14,818.52 | 29.63K |
Scheduled
|
Jul 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| -3.05% | -1.00K |
$8.65 | -$8,617.29 | 31.61K |
Scheduled
|
Oct 2
| ||
Form 4
| -2.96% | -1.00K |
$9.53 | -$9,489.89 | 32.6K |
Scheduled
|
Jul 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4/A
| +8.92% | 984 |
$9.30 | $9,778.05 | 12.02K |
Scheduled
|
Apr 1 - Apr 2
| ||
Form 4/A
| +8.33% | 985 |
$11.55 | $11,643.80 | 12.81K |
Scheduled
|
Jan 1 - Jan 2
| ||
Form 4/A
|
∞
| 11.83K |
$11.39 | $140,178.70 | 11.83K |
Scheduled
|
Dec 23 - Dec 26
| ||
Form 4
| +8.92% | 984 |
$9.30 | $9,778.05 | 12.02K |
Scheduled
|
Apr 1 - Apr 2
| ||
Form 4
| +8.33% | 985 |
$11.55 | $11,643.80 | 12.81K |
Scheduled
|
Jan 1 - Jan 2
| ||
Form 4/A
|
∞
| 11.83K |
$11.39 | $140,178.70 | 11.83K |
Scheduled
|
Dec 23 - Dec 26
| ||
Form 4
|
∞
| 11.83K |
$11.39 | $140,178.70 | 11.83K |
Scheduled
|
Dec 23 - Dec 26
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||